Hippocratic AI, a pioneering leader in transforming medical education and practice through innovative artificial intelligence solutions, has successfully raised an impressive $118 million in its latest funding round. This significant investment underscores the growing recognition of AI's potential to enhance medical training and patient care, positioning Hippocratic AI at the forefront of healthcare innovation. Founded with a mission to put patients at the heart of medical education, Hippocratic AI leverages cutting-edge data and algorithms to develop tools that augment human intelligence and empathy, rather than replace them. This latest influx of capital will be instrumental in expanding the company's offerings and accelerating the development of its AI-powered platforms. By providing medical students and healthcare professionals with intelligent resources and insights, Hippocratic AI aims to foster better outcomes for patients and revolutionize the way healthcare is delivered. The funds will facilitate strategic partnerships, enhance research initiatives, and fuel the development of new product features that resonate with the needs of physicians and their patients. As the healthcare sector continues to evolve, Hippocratic AI is committed to shaping a future where technology not only supports medical practitioners but also enriches the patient experience, ensuring that empathy remains an integral component of care. With this funding, Hippocratic AI is poised to make significant strides in improving medical education and practice, further solidifying its position as a game changer in the healthcare landscape.

Hippocratic AI Secures $118 Million in Series A Funding to Revolutionize Medical Education and Practice with AI
Get the full Hippocratic AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
P2 Science, Inc.
We are the New Green Chemistry Company with a mission to de-carbonize the chemical industry, using the power of green chemistry.
$23.0M Unknown
today

Backoffice Solutions, Inc.
Backoffice Solutions, Inc. (BSI) is a domestic corporation that offers back-office support to micro, small and medium Enterprises, sole proprietors or self-employed individuals. Registered under the Securities Exchange Commission (SEC) since 14 August 2012. Our company has worked with varied private sector companies and organizations, allowing us to develop expertise in the following sectors: * Online Market Place * Restaurants and Food Chains * Forwarding Business * Travel & Tours * Advertising & Marketing * Domestic Manpower Agency * Hotels, Resorts & Tourism * International Manning Agency * Training School * Ship Management
$163.5K Unknown
today

Evolve Neuro
Transforming ADHD diagnosis with proprietary neuroscience and AI. Our 10-minute EEG-based assessment unlocks scalable, evidence-backed insights — targeting a global market underserved by outdated, subjective methods.
$1.9M Seed
today

Phytolon
Phytolon offers natural food colors, uniquely positioned to comply with the consumers needs for healthy food, and with the industry requirements for cost-efficiency and high quality. Phytolon leverages a novel and sustainable fermentation-based technology by which betalain natural colors are produced in baker's yeast.
$23.6M Series b
today

OZOREON
Our (H)unit® is a robust offgrid adapted ozone generator, built to last. With proprietary components and design it can withstand any humidity in the feed gas. We offer it as a stand-alone product or included in an automation cabinet. As an add-on we also provide a customized offgrid power-supply kit. The beneficial combination of ozone and high humidity is a known fact in the industry, and has been documented for 80+ years. The synergistic effects causes higher oxidizing and disinfecting properties than a dry ozone treatment does. And OZOREON has the technology for it.
$320.0K Unknown
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | ![]() Riboscience United States | Series a | $146.8M | today |
| 2 | ![]() Passage Ticketing United States | Series a | $610.0K | today |
| 3 | ![]() InvestorHub Australia | Series a | $3.0M | 1d ago |
| 4 | ![]() Mister IA France | Series a | $10.0M | 1d ago |
| 5 | ![]() OneReg New Zealand | Series a | $4.4M | 1d ago |




